Anhui Tianqianjian Food Technology Co., Ltd., established on 2016-08-08, Business scope includes bioscience and technology research services;Chinese Medicine Technology Research Service;Containing tea products and substitute teas,seasoning(solid state),Solid beverage production and sales;Purchase and sale of agricultural and sideline products.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Chongqing Xiaowan Biotechnology Co., Ltd., established on 2004-07-07, Business scope includes licensed projects:medical supplements(sugar pill)Production;Import and export,Production of daily chemical raw materials(Pellets)(Free of chemical hazards);Cosmetic production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Research and development and service of microcapsule and pellet technology(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Wuxi Zhongke Guangyuan Biomaterials Co., Ltd., established on 2008-07-24, Business scope includes licensed projects:Production of Class II Medical Devices;Production of Class III Medical Devices(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Sales of bio-based materials;Import and export;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Production of Class I Medical Devices(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

CABIO Biotech (Wuhan) Co., Ltd. engages in the research, development, production, and sale of polyunsaturated fatty acids and nutrition products. Its products include arachidonic acids (ARA), docosahexaenoic acids (DHA), natural beta-carotene products, infant formula food, functional healthcare food, and dietary supplements. The company was founded on September 22, 2004 and is headquartered in Wuhan, China.

Tianjin Famoxi Pharmaceutical Technology Co., Ltd., established on 2008-09-24, Business scope includes biotechnology,medical technology(Except narcotic drugs and psychotropic substances),development of chemical technology,consult,Serve;Chemical Products(Dangerous goods and precursor drugs are excluded),Sodium silicate(water glass)Wholesale and retail;Import and export of goods and technology(law,Except as otherwise provided by administrative regulations);Pharmaceutical Intermediates(Hazardous chemicals and precursor drugs are excluded)Manufacturing and sales;Computer Network Technology Consulting Services;Medical Device Sales;Hazardous chemicals without storage operation(Subject to the scope of the hazardous chemicals business license).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

China National Research Institute of Food & Fermentation is a Chinese company located in Beijing and ultimately controlled by the Government of China. The firm develops food manufacturing related technology.

Shanghai Grand Cosmetics Co., Ltd., established on 1994-08-18, Business scope includes licensed projects:Cosmetic production;Import and export;Technology Import and Export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:Production of cosmetic appliances and after-sales service,Sell ​​self-produced products;Manufacture of special equipment for daily necessities production;Manufacturing of special equipment(Manufacture of licensed professional equipment not included),Professional cleaning,to clean,Disinfection service,Chemical Products(No licensed chemical products),Specialty Chemicals(Free of Hazardous Chemicals),Disinfection product sales(Free of Hazardous Chemicals),Daily necessities,daily necessities,personal hygiene products,Equipment,Instrumentation,Packaging materials and products,paper products,plastic products,Daily glass products,technical glass,Packaging special equipment sales;Industrial Engineering Design Services;Graphic design and production;Professional Design Services.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Dexerials Corp. engages in the manufacture and sale of optical, electronic and adhesive materials. It operates through the following segments: Optics Materials and Electronic Component Products segments. The Optic Materials segment provides optical elasticity resins(SVR), optical films, UV curable resin for optical disks, inorganic wave plates and inorganic polarizers. The Electronic Component Products segment provides industrial functional bonding material, anisotropic conductive film, surface mounted type fuse, and inorganic polarizing plate. The company was founded on March 5, 1962 and is headquartered in Tokyo, Japan.

Xi'an Yingpu Biotechnology Co., Ltd., established on 2000-09-18, The business scope includes the production of cosmetics;Research and development of bio-health daily necessities,Sales;Raw materials for bioactive substances,Research and development of pharmaceutical intermediates;Import and export business of goods and technology;Cosmetics commissioned processing.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shanghai Mingnuo Environmental Technology Co., Ltd., established on 2008-01-10, Business scope includes technological development in the field of environmental engineering,technology transfer,technical consulting,Technical Services;Engineering Project Management;Green facilities,Electrical Equipment,Hardware and building materials sales;construction work,Environmental Engineering. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Inner Mongolia Yili Industrial Group Co., Ltd. engages in the processing, manufacturing, and sales of all types of dairy products and health drinks. Its products include liquid milk, milk drinks, milk powder, frozen drinks, yogurt, health drinks, ice cream and cheese products. The company's product series and services consist of six business groups, they are the liquid milk, milk powder, cold drinks, yogurt, health drinks and cheese. Inner Mongolia Yili Industrial Group was founded on June 4, 1993 and is headquartered in Hohhot, China.

Diqi Pharmaceutical focuses on the development of drug technology and the industrialization of products. The company has 6 innovative technology platforms with independent intellectual property rights, including long-acting preparation technology, targeted nanotechnology, and sustained and controlled release technology.

Nanjing Zelang Pharmaceutical Technology Co., Ltd., established on 2008-01-08, The business scope includes the development of plant extracts,processing,Sales and related technology transfer and service;medicine,food,Health food research and development;Cosmetic sales,Primary Agricultural Sales;cereals,vegetable,planting of flowers;Promotion of planting technology of Chinese herbal medicines.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment businesses; Connected Care businesses; Personal Health businesses; and Other. The Diagnosis and Treatment businesses segment consists systems, smart devices, software and services, powered by AI-enabled informatics-that support precision diagnoses and minimally invasive procedures in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care businesses segment consists Hospital Patient Monitoring, Emergency Care, Sleep & Respiratory Care and Connected Care Informatics. The Personal Health businesses segment consists of Oral Healthcare, Personal Care,Mother and Child Care. The Other segment reports on the items Innovation & Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Inner Mongolia Milk Industry Group is a Chinese private company. The firm operates as dairy farm.

Runying Bioengineering (Shanghai) Co., Ltd., established on 2006-09-22, Business scope includes licensed projects:food production;food sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:Technology Import and Export;Import and export;Food import and export;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Bio-feed R&D.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Zhaoqing Juyuan Biochemical Co., Ltd., established on 2006-11-10, Business scope includes production,Sales:vitamins,Colorant,flavoring agent.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Part of Guangdong Zhongsheng Pharmaceutical Co., Ltd., Guangdong Xianqiang Pharmaceutical Co. Ltd. is a Chinese company located in Guangzhou. The firm manufactures and distributes pharmaceutical products. On March 22, 2015 Guangdong Zhongsheng Pharmaceutical Co., Ltd. acquired Guangdong Xianqiang Pharmaceutical Co. Ltd. for $204.63 million.